Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Avita Medical Inc (RCEL)

77 + Investors. Track Smart Money conviction in RCEL. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +10
Streak
1Q ▲
Buyers last Q
66%

Smart Money Signals — RCEL

Based on 77 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added RCEL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (96% of max)

96% of all-time peak
77 hedge funds hold RCEL right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding RCEL is almost the same as a year ago (+0 funds, +0% change). No significant rush to buy or sell — institutional backing is holding steady.
🟢

More buyers than sellers — 66% buying

53 buying27 selling
Last quarter: 53 funds were net buyers (26 opened a brand new position + 27 added to an existing one). Only 27 were sellers (11 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter
Funds opening a new RCEL position: 16 → 17 → 8 → 26. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

49% of holders stayed for 2+ years

■ 49% conviction (2yr+) ■ 18% medium ■ 32% new
38 out of 77 hedge funds have held RCEL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +1680%, value +1235%

Value
+1234%
Shares
+1680%
Last quarter: funds added +1680% more shares while total portfolio value only changed +1235%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~26 new funds/quarter

16 → 16 → 17 → 8 → 26 new funds/Q
New funds entering each quarter: 16 → 17 → 8 → 26. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 51% veterans vs 33% newcomers

■ 51% veterans ■ 15% 1-2yr ■ 33% new
Entry-cohort mix of 78 holders: 40 (51%) are 2+ year veterans, 12 entered 1–2 years ago, and 26 (33%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 10% AUM from top-100

10% from top-100 AUM funds
25 of 76 holders rank in the top 100 by AUM, but together hold only 10% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RCEL

In 2026 Q1, 53 hedge funds were net buyers of RCEL (26 opened a new position, 27 added to an existing one), while 27 reduced or exited (11 trimmed, 16 sold completely) — a 66% buyer ratio, indicating clear institutional accumulation. Net fund flow last quarter: +10 funds (more new holders than closures). Total institutional holders: 77.

Hedge Fund Ownership: RCEL

How many hedge funds hold RCEL — quarterly history vs. share price
Quarterly hedge fund ownership of RCEL vs. share price

Market Analysis: RCEL

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RCEL

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Avita Medical Inc (RCEL) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much RCEL has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
RCEL
+8.4%
XLV
+2.1%

RCEL outperformed XLV by +6.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
RCEL
-12.1%
XLV
+3.2%

Since the filing became public, RCEL outperformed XLV by -15.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

13 top-rated funds 0 high-conviction
Consensus
5.0
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: RCEL
77 + Investors

Track Smart Money conviction in RCEL. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 77 67 14.93%
13F Shares 87M 5M 1680.23%
Total Value $226M $17M 1234.5%
New Positions 26 8 +18
Increased Positions 26 15 +11
Closed Positions 16 19 -3
Reduced Positions 11 29 -18
Total Calls 2 2 -
Total Puts 0 1 -100.0%
PUT/CALL Ratio 0.0 0.5 Bullish

Statistics: RCEL

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

77 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RCEL. Verified SEC 13F-HR filings.

QUARTER:
Top 25 RCEL holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Orbimed Advisors LLC 3.06% 40,966,100 $154.4M
2 Thompson Davis & CO., INC. 0.10% 39,050 $144K
3 R Squared Ltd 0.03% 15,285 $57K
4 Divisadero Street Capital Management, LP 0.02% 100,000 $370K
5 Abel Hall, LLC 0.01% 16,810 $62K
6 China Universal Asset Management Co., Ltd. 0.00% 10,000 $37K
7 Bridgeway Capital Management, LLC 0.00% 30,404 $112K
8 IHT Wealth Management, LLC 0.00% 25,100 $93K
9 AlphaQuest LLC 0.00% 9,378 $32K
10 Essential Partners LLC 0.00% 645 $2K
11 Strs Ohio 0.00% 47,700 $176K
12 Engineers Gate Manager LP 0.00% 12,826 $47K
13 Tower Research Capital LLC (TRC) 0.00% 4,029 $15K
14 Gabelli Funds LLC 0.00% 15,000 $56K
15 Macquarie Group Ltd 0.00% 11,902 $44K
16 Ameritas Investment Partners, Inc. 0.00% 2,076 $8K
17 GAMMA Investing LLC 0.00% 1,172 $4K
18 Marshall Wace, LLP 0.00% 52,562 $194K
19 Vanguard Fiduciary Trust Co 0.00% 193,436 $716K
20 Sound Income Strategies, LLC 0.00% 1,000 $4K
21 Versant Capital Management, Inc 0.00% 441 $2K
22 Aqr Capital Management LLC 0.00% 94,361 $349K
23 Quantinno Capital Management LP 0.00% 22,483 $83K
24 Vanguard Capital Management LLC 0.00% 1,335,152 $4.9M
25 Rhumbline Advisers 0.00% 26,645 $99K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Avita Medical Inc (RCEL)

What does the Smart Money Trend signal show for RCEL?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added RCEL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for RCEL?

More buyers than sellers — 66% buying: Last quarter: 53 funds were net buyers (26 opened a brand new position + 27 added to an existing one). Only 27 were sellers (11 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for RCEL holders?

Smaller funds dominant — 10% AUM from top-100: 25 of 76 holders rank in the top 100 by AUM, but together hold only 10% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held RCEL?

49% of holders stayed for 2+ years: 38 out of 77 hedge funds have held RCEL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Avita Medical Inc (RCEL) following the 2026 Q1 hedge fund 13F filings?

As of today, RCEL has moved -12.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of -15.3%. Since the quarter end (March 31, 2026), RCEL has gained +8.4% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →